These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 16973621)
1. A protease pathway for the repair of topoisomerase II-DNA covalent complexes. Zhang A; Lyu YL; Lin CP; Zhou N; Azarova AM; Wood LM; Liu LF J Biol Chem; 2006 Nov; 281(47):35997-6003. PubMed ID: 16973621 [TBL] [Abstract][Full Text] [Related]
2. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Lyu YL; Kerrigan JE; Lin CP; Azarova AM; Tsai YC; Ban Y; Liu LF Cancer Res; 2007 Sep; 67(18):8839-46. PubMed ID: 17875725 [TBL] [Abstract][Full Text] [Related]
3. Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks. Lin CP; Ban Y; Lyu YL; Liu LF J Biol Chem; 2009 Oct; 284(41):28084-28092. PubMed ID: 19666469 [TBL] [Abstract][Full Text] [Related]
4. Repair of trapped topoisomerase II covalent cleavage complexes: Novel proteasome-independent mechanisms. Tsuda M; Kitamasu K; Hosokawa S; Nakano T; Ide H Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):170-184. PubMed ID: 31608820 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors. Sergei B; Pavel D; Aigul G; Firyuza B; Ilmira N; Ilshat M; Aida A; Refat K; Natalia A; Elena S; Vera G Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948066 [TBL] [Abstract][Full Text] [Related]
6. Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Azarova AM; Lyu YL; Lin CP; Tsai YC; Lau JY; Wang JC; Liu LF Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11014-9. PubMed ID: 17578914 [TBL] [Abstract][Full Text] [Related]
7. The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway. Xiao H; Mao Y; Desai SD; Zhou N; Ting CY; Hwang J; Liu LF Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3239-44. PubMed ID: 12629207 [TBL] [Abstract][Full Text] [Related]
8. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death. Calderón-Montaño JM; Burgos-Morón E; Orta ML; Pastor N; Perez-Guerrero C; Austin CA; Mateos S; López-Lázaro M Pharmacol Rep; 2012; 64(6):1515-25. PubMed ID: 23406762 [TBL] [Abstract][Full Text] [Related]
9. Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia. Azarova AM; Lin RK; Tsai YC; Liu LF; Lin CP; Lyu YL Biochem Biophys Res Commun; 2010 Aug; 399(1):66-71. PubMed ID: 20638367 [TBL] [Abstract][Full Text] [Related]
10. Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA Complexes. Lee KC; Swan RL; Sondka Z; Padget K; Cowell IG; Austin CA Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011940 [TBL] [Abstract][Full Text] [Related]
11. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation. Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512 [TBL] [Abstract][Full Text] [Related]
12. A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes. Lin CP; Ban Y; Lyu YL; Desai SD; Liu LF J Biol Chem; 2008 Jul; 283(30):21074-83. PubMed ID: 18515798 [TBL] [Abstract][Full Text] [Related]
13. 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. Mao Y; Desai SD; Ting CY; Hwang J; Liu LF J Biol Chem; 2001 Nov; 276(44):40652-8. PubMed ID: 11546768 [TBL] [Abstract][Full Text] [Related]
14. DNA double-strand breaks with 5' adducts are efficiently channeled to the DNA2-mediated resection pathway. Tammaro M; Liao S; Beeharry N; Yan H Nucleic Acids Res; 2016 Jan; 44(1):221-31. PubMed ID: 26420828 [TBL] [Abstract][Full Text] [Related]
15. Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage. Malik M; Nitiss KC; Enriquez-Rios V; Nitiss JL Mol Cancer Ther; 2006 Jun; 5(6):1405-14. PubMed ID: 16818498 [TBL] [Abstract][Full Text] [Related]
16. Requirements for MRN endonuclease processing of topoisomerase II-mediated DNA damage in mammalian cells. Sun Y; Soans E; Mishina M; Petricci E; Pommier Y; Nitiss KC; Nitiss JL Front Mol Biosci; 2022; 9():1007064. PubMed ID: 36213114 [TBL] [Abstract][Full Text] [Related]
17. Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II. Lee KC; Bramley RL; Cowell IG; Jackson GH; Austin CA Biochem Pharmacol; 2016 Mar; 103():29-39. PubMed ID: 26794000 [TBL] [Abstract][Full Text] [Related]
18. Topoisomerase IIβ associates with Ku70 and PARP-1 during double strand break repair of DNA in neurons. Mandraju R; Chekuri A; Bhaskar C; Duning K; Kremerskothen J; Kondapi AK Arch Biochem Biophys; 2011 Dec; 516(2):128-37. PubMed ID: 22019940 [TBL] [Abstract][Full Text] [Related]
19. Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock. Ban Y; Ho CW; Lin RK; Lyu YL; Liu LF Mol Cell Biol; 2013 Oct; 33(20):4008-16. PubMed ID: 23938298 [TBL] [Abstract][Full Text] [Related]
20. Loss of histone H2AX increases sensitivity of immortalized mouse fibroblasts to the topoisomerase II inhibitor etoposide. Donà F; Prosperi E; Savio M; Coppa T; Scovassi AI; Mondello C Int J Oncol; 2008 Sep; 33(3):613-21. PubMed ID: 18695893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]